ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.780
-0.090 (-1.85%)
At close: Sep 16, 2025, 4:00 PM EDT
4.750
-0.030 (-0.63%)
After-hours: Sep 16, 2025, 5:20 PM EDT
ENDRA Life Sciences Employees
ENDRA Life Sciences had 21 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$417,397
Market Cap
3.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21 | 0 | - |
| Dec 31, 2023 | 21 | 0 | - |
| Dec 31, 2022 | 21 | -1 | -4.55% |
| Dec 31, 2021 | 22 | 4 | 22.22% |
| Dec 31, 2020 | 18 | 3 | 20.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NDRA News
- 4 weeks ago - ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard - Business Wire
- 4 months ago - ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results - Business Wire
- 6 months ago - ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies - Business Wire
- 6 months ago - ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update - Business Wire
- 10 months ago - ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
- 10 months ago - ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 11 months ago - Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024 - Business Wire